16 May 2008

Chinese moss for Alzheimers?

An extract from Chinese club moss shows promise as a treatment for people with Alzheimer's disease, researchers report after analysing combined data from multiple trials.

An extract from Chinese club moss shows promise as a treatment for people with Alzheimer's disease, researchers report after analysing combined data from multiple trials conducted in China.

However, there is insufficient evidence to currently support routine use of the extract, known as Huperzine A, for Alzheimer's patients, report in The Cochrane Library, a publication of the Cochrane Collaboration, an international organisation that evaluates medical research.

Huperzine A is an extract of Huperzia serrata, a traditional Chinese medicine plant commonly referred to as Chinese club moss.

Other research has suggested Huperzine A may have some benefit in the management of Alzheimer's disease, the investigators note, but previous multiple-study reviews involved only English-language research.

How the study was done
To gain a better understanding of the effects of Huperzine A in Alzheimer's disease, Hongmei Wu, of Sichuan University in Chengdu, China, and colleagues performed an all-language multiple-study review. They analysed six randomised controlled trials that assessed the efficacy and safety of Huperzine A in a total of 454 patients with Alzheimer's disease.

The data suggest, the researchers report, that compared with placebo or usual care, Huperzine A may improve measures of thinking and memory, behaviour disturbances, and Alzheimer's disease patients' performance of daily functions.

However, the trials were of low "methodological" quality, they point out. The researchers did not identify obvious adverse effects among patients treated with Huperzine A, but they note that many of the studies did not sufficiently report adverse effects.

Findings will lead to more research
While data from studies to date do not support the current use of Huperzine A for Alzheimer's disease, findings from this and other studies warrant further research in large randomised, controlled trials of adequate duration and that sufficiently follow patient groups for adverse events and outcomes, the investigators conclude.

"These findings are based on a small number of trials, but the data indicate that it would be well worth setting up some more high quality assessments of this interesting drug," Wu added in a statement issued by The Cochrane Library. (Reuters Health, May 2008)

Read more:
Fruit, veg to fight Alzheimers?
Early Alzheimer's for drinkers


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Live healthier

Coffee and wine for the win! »

Could heartburn drugs upset your 'good' gut bacteria? Life is a gut reaction

Good news! Coffee & wine may promote a healthy gut

Diverse bacteria help your gut stay healthy. Here's how what you eat and drink can help or harm that balance - and it's not all bad news.

I gave hubby HIV »

Giving babies antibodies promptly may eliminate HIV Vaginal ring to prevent HIV on the cards

I gave my husband HIV and watched him die

Stephanie van Niekerk unwittingly infected her husband with HIV and ended up having to watch him wither and die in front of her very eyes. This is Stephanie's story in her own words.